Format

Send to

Choose Destination
See comment in PubMed Commons below
Drugs Today (Barc). 2006 Sep;42(9):577-85.

Ruboxistaurin.

Author information

1
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27705-0493, USA. joy00002@mc.duke.edu

Abstract

Ruboxistaurin is a potent and specific inhibitor of the beta isoform of protein kinase C. Overactivation of protein kinase C has been demonstrated in patients with type 2 diabetes, and is postulated to play a major role in the pathogenesis of diabetic microvascular complications, which include diabetic retinopathy, neuropathy and nephropathy. The role of protein kinase C in promoting tissue injury in patients with diabetes, and the pharmacologic and clinical studies illustrating the potential of ruboxistaurin to reduce the burden of diabetic microvascular complications will be discussed in this article.

PMID:
17028667
DOI:
10.1358/dot.2006.42.9.996566
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Clarivate Analytics
    Loading ...
    Support Center